Raymond Niaura Selected Research

Substance Withdrawal Syndrome (Withdrawal Symptoms)

1/2015	Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.
5/2009	A prospective examination of distress tolerance and early smoking lapse in adult self-quitters.
3/2008	Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.
12/2003	Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond Niaura Research Topics

Disease

11	Tobacco Use Disorder (Nicotine Dependence) 10/2020 - 12/2003
4	COVID-19 01/2021 - 01/2020
4	Substance-Related Disorders (Drug Abuse) 01/2017 - 10/2004
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2015 - 12/2003
2	Insulin Resistance 09/2006 - 04/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2003 - 04/2003
1	Birth Weight (Birth Weights) 01/2022
1	Inflammation (Inflammations) 10/2021
1	Cough 01/2018
1	Diarrhea 01/2018
1	Vomiting 01/2018
1	Constipation 01/2018
1	Headache (Headaches) 01/2018
1	Nausea 01/2018
1	Marijuana Use 01/2017
1	Coronary Disease (Coronary Heart Disease) 04/2015
1	Anhedonia 09/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2009
1	Anxiety Disorders (Anxiety Disorder) 05/2009
1	Mental Disorders (Mental Disorder) 05/2009
1	Hypertension (High Blood Pressure) 01/2008
1	Major Depressive Disorder (Major Depressive Disorders) 07/2007
1	Weight Gain 10/2006
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2005
1	Depressive Disorder (Melancholia) 03/2005
1	Premenstrual Dysphoric Disorder 04/2004
1	Obesity 04/2003

Drug/Important Bio-Agent (IBA)

10	Nicotine FDA Link 01/2022 - 04/2004
3	Pharmaceutical PreparationsIBA 01/2020 - 03/2004
3	Bupropion (Wellbutrin)FDA LinkGeneric 03/2008 - 12/2003
2	CotinineIBA 01/2022 - 04/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	Indicators and Reagents (Reagents)IBA 03/2014 - 11/2007
2	Dopamine (Intropin)FDA LinkGeneric 12/2013 - 12/2003
1	hydroxycotinineIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	Tocopherols (Tocopherol)IBA 01/2019
1	RimonabantIBA 01/2018
1	Menthol FDA Link 01/2017
1	nasIBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2015
1	Varenicline (Chantix)FDA Link 01/2015
1	GlucocorticoidsIBA 01/2014
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 09/2011
1	Medical MarijuanaIBA 07/2009
1	CholesterolIBA 01/2008
1	Naltrexone (ReVia)FDA LinkGeneric 10/2006
1	SmokeIBA 10/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2006
1	Insulin (Novolin)FDA Link 09/2006
1	Glucose (Dextrose)FDA LinkGeneric 09/2006
1	Biological ProductsIBA 11/2005
1	Antipsychotic Agents (Antipsychotics)IBA 10/2004
1	Fluoxetine (Prozac)FDA LinkGeneric 04/2004
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2003
1	Hormones (Hormone)IBA 10/2003
1	LipidsIBA 04/2003

Therapy/Procedure

2	Cardiac Rehabilitation 05/2009 - 03/2005
1	Nicotine Replacement Therapy 06/2009
1	Tobacco Use Cessation Devices 03/2007